Study of ATI-1777 in Patients 12 to 65 Years Old With Mild to Severe Atopic Dermatitis
Trial details
- Registry ID
- NCT05432596
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as Placebo
| No regulatory events match this view.This does not mean no FDA events have occurred. |